Oncology clinical practice guidelines usage among physicians in Nepal.
Nepal
cancer
clinical guidelines
low resource settings
low- and middle-income countries
oncology clinical guidelines
Journal
Journal of evaluation in clinical practice
ISSN: 1365-2753
Titre abrégé: J Eval Clin Pract
Pays: England
ID NLM: 9609066
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
14
06
2021
received:
28
03
2021
accepted:
17
06
2021
pubmed:
30
6
2021
medline:
3
2
2022
entrez:
29
6
2021
Statut:
ppublish
Résumé
Oncology clinical practice guidelines (OCPGs) are systematically developed evidence-based recommendations aimed to guide practitioners in decision making during the diagnosis, management, and treatment of cancer patients under specific circumstances, thereby optimizing clinical outcomes. However, little is known about the implementation of those guidelines in low and middle-income countries including Nepal. This research aimed to identify the type of OCPGs used by Nepalese physicians working in oncology departments and to explore barriers and facilitators affecting their use. Using the total population sampling technique, we conducted an online cross-sectional survey from June 2020 to January 2021 among physicians working in the oncology departments of Nepal. Descriptive analyses were conducted to summarize the research findings. Out of 171 physicians approached for the study, 102 (59.6%) responded to the questionnaire. The sizable proportions of the participants were a senior group of physicians with 27.5% being consultants, 14.7% senior consultants, and 16.7% professors. The most commonly used guideline was the National Comprehensive Cancer Network guideline of the United States (75.5%) followed by the American Society of Clinical Oncology guideline (44.7%). While only 22.6% of physicians reported using OCPGs every time, more than half (56.9%) highlighted that OCPGs are not feasible to implement in Nepal. Insufficient facilities/equipment, physicians' unwillingness to change their usual practice, inability to discuss research with knowledgeable colleagues, and lack of time were commonly cited barriers. Findings of our study highlighted that the OCPGs developed in high-income countries may not be feasible for low resource settings like Nepal. Comprehensive local OCPGs should be developed considering the available resources, feasibility, and financial constraints of patients. Furthermore, a constant sharing and learning environment should be created to enhance the knowledge of practicing physicians and to promote the proper implementation of evidence-based findings.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
142-150Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
International Agency for Research on Cancer. World Health Organization. Global Cancer Observatory. Estimated number of new cases in 2020, worldwide, both sexes, all ages. https://gco.iarc.fr/. Accessed January 3, 2021.
Nepal Health Research Council. Population Based Cancer Registry in Nepal. Interim Analysis of Data from January-May 2018 Progress Report, November, 2018.; 2018. http://nhrc.gov.np/wp-content/uploads/2019/04/Progress-Interim-_cancer.pdf. Accessed January 3, 2021.
Poudel KK, Huang Z, Neupane PR. Trend of cancer incidence in Nepal from 2003 to 2012. Asian Pacific J Cancer Prev. 2016;17(4):2171-2175. https://doi.org/10.7314/APJCP.2016.17.4.2171.
Bhandari D, Shibanuma A, Kiriya J, Hirachan S, Ong KIC, Jimba M. Factors associated with breast cancer screening intention in Kathmandu Valley, Nepal. Pakpour AH, ed. PLoS One. 2021;16(1):e0245856. https://doi.org/10.1371/journal.pone.0245856.
Selmouni F, Zidouh A, Belakhel L, et al. Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar. Lancet Oncol. 2018;19(2):e93-e101. https://doi.org/10.1016/S1470-2045(17)30727-1.
Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493-1505. https://doi.org/10.1016/S1470-2045(19)30456-5.
Jara C, Del Barco S, Grávalos C, et al. SEOM clinical guideline for treatment of cancer pain (2017). Clin Transl Oncol. 2018;20(1):97-107. https://doi.org/10.1007/s12094-017-1791-2.
Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. J Pain Res. 2016;9:515-534. https://doi.org/10.2147/JPR.S97759.
Rauh S, Arnold D, Braga S, et al. Challenge of implementing clinical practice guidelines. Getting ESMO's guidelines even closer to the bedside: introducing the ESMO Practising oncologists checklists and knowledge and practice questions. ESMO Open. 2018;3(5):e000385. https://doi.org/10.1136/esmoopen-2018-000385.
Adhikari KP. A medical physics perspective: radiation therapy in Nepal. Vol 6.; 2018. http://www.who.int/mediacentre/releases/2003/pr27/en/. Accessed January 3, 2021.
Ismaila N, Salako O, Mutiu J, Adebayo O. Oncology guidelines usage in a low- and middle-income country. J Glob Oncol. 2018;4:1-6. https://doi.org/10.1200/JGO.17.00136.
Williams B, Brown T, Costello S. A cross-cultural investigation into the dimensional structure and stability of the barriers to research and utilization scale (BARRIERS scale). BMC Res Notes. 2015;8(1):1-12. https://doi.org/10.1186/s13104-015-1579-9.
Funk SG, Champagne MT, Wiese RA, Tornquist EM. Barriers: the barriers to research utilization scale. Appl Nurs Res. 1991;4(1):39-45. https://doi.org/10.1016/S0897-1897(05)80052-7.
Kerr S, Jazieh AR, Kerr D. How useful are international treatment guidelines in low- and middle-income countries? J Glob Oncol. 2017;3(5):441-443. https://doi.org/10.1200/JGO.2016.008250.
National Comprehensive Cancer Network. NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™). https://www.nccn.org/framework/. Accessed January 3, 2021.
Mercuri M, Sherbino J, Sedran RJ, Frank JR, Gafni A, Norman G. When guidelines don't guide: the effect of patient context on management decisions based on clinical practice guidelines. Acad Med. 2015;90(2):191-196. https://doi.org/10.1097/ACM.0000000000000542.
Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines?: a framework for improvement. JAMA. 1999;282(15):1458-1465. https://doi.org/10.1001/jama.282.15.1458.
Government of Nepal. Nepal Health Research Council. Assessment of Social Health Insurance Scheme in Selected Districts of Nepal.; 2018. http://nhrc.gov.np/wp-content/uploads/2019/04/Health-Insurence-CTP.pdf. Accessed January 3, 2021.
Baradaran-Seyed Z, Nedjat S, Yazdizadeh B, Nedjat S, Majdzadeh R. Barriers of clinical practice guidelines development and implementation in developing countries: a case study in Iran. Int J Prev Med 2013;4(3):340-348. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23626892/?tool=EBI. Accessed January 3, 2021.
Family Health Division, Ministry of Health and Population. National Guidelines for Cervical Cancer Screening and Prevention in Nepal.; 2010. https://screening.iarc.fr/doc/SAcervical-cancer.pdf. Accessed January 3, 2021.
Lugtenberg M, Zegers-Van Schaick JM, Westert GP, Burgers JS. Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4(1):54. https://doi.org/10.1186/1748-5908-4-54.
Joosen MC, van Beurden KM, Terluin B, van Weeghel J, Brouwers EP, van der Klink JJ. Improving occupational physicians' adherence to a practice guideline: feasibility and impact of a tailored implementation strategy. BMC Med Educ. 2015;15(1):82. https://doi.org/10.1186/s12909-015-0364-8.
Lesslie M, Parikh J. Implementing a multidisciplinary tumor Board in the Community Practice Setting. Diagnostics. 2017;7(4):55. https://doi.org/10.3390/diagnostics7040055.
Lamb BW, Green JSA, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients. J Am Coll Surg. 2013;217(3):412-420. https://doi.org/10.1016/j.jamcollsurg.2013.04.035.